Patent 7432046 was granted and assigned to Abbott on October, 2008 by the United States Patent and Trademark Office.
The present invention relates to methods of determining anti-infectious agent IgG avidity, for example, human anti-cytomegalovirus and human anti-toxoplasma IgG avidity, using a competitive assay format.